Use of gene set analysis (GSA) for molecular classification of responders and nonresponders to FOLFOX therapy in colorectal cancer (CRC).
Stephen Yip
No relevant relationships to disclose
Maggie Chon U. Cheang
No relevant relationships to disclose
Hagen F. Kennecke
No relevant relationships to disclose